Stage III Non-Small Cell Lung Cancer AJCC v7 Active Not Recruiting Phase 1 Trials for Navitoclax (DB12340)

Also known as: Stage III Lung Non-Small Cell Cancer AJCC v7

IndicationStatusPhase
DBCOND0090379 (Stage III Non-Small Cell Lung Cancer AJCC v7)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02520778Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung CancerTreatment